Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹12,527 Cr
Revenue (TTM)
₹1,782 Cr
Net Profit (TTM)
₹348 Cr
ROE
16 %
ROCE
20.4 %
P/E Ratio
36
P/B Ratio
4.2
Industry P/E
36.03
EV/EBITDA
21.8
Div. Yield
0.3 %
Debt to Equity
0.1
Book Value
₹294.7
EPS
₹34.8
Face value
5
Shares outstanding
101,359,490
CFO
₹1,368.77 Cr
EBITDA
₹2,114.61 Cr
Net Profit
₹1,392.95 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Poly Medicure
| -30.1 | -5.2 | -31.0 | -44.5 | 8.8 | 8.4 | 23.8 |
|
BSE Healthcare
| -4.0 | -3.8 | -4.0 | 3.0 | 24.6 | 15.5 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Poly Medicure
| -33.8 | 78.0 | 65.9 | -6.3 | 88.1 | 132.9 | -2.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Poly Medicure
|
1,240.5 | 12,526.5 | 1,781.6 | 341.3 | 19.8 | 12.4 | 36 | 4.2 |
| 251.4 | 143.7 | 34.5 | -3.4 | -5.4 | -48.6 | -- | 10.5 | |
| 1,596.8 | 26,315.7 | 6,112.8 | 847.2 | 17.2 | 9.2 | 31.1 | 2.7 | |
| 177.2 | 973.9 | 264.6 | 19.3 | 8.9 | 6.2 | 42 | 4.2 | |
| 131.8 | 72.6 | 35.4 | 5.8 | 15.4 | 17 | 12.6 | 1.8 | |
| 820.6 | 9,847.5 | 6,537.7 | 207.0 | 4.6 | 11.5 | 47.6 | 5.2 | |
| 241.3 | 229.8 | 143.3 | 10.6 | 3.5 | 5.4 | 21.6 | 1.2 | |
| 76.0 | 147.0 | 173.0 | 13.5 | 12.9 | 12.1 | 12.5 | -- | |
| 70.0 | 92.1 | 79.3 | 8.6 | 13.0 | 30.6 | 10.7 | 3.0 | |
| 182.3 | 969.2 | 414.3 | 20.3 | 8.0 | 3.4 | 47.6 | 1.5 |
1 min read•By Research Desk
Poly Medicure Limited manufactures and sells medical devices in India and internationally. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged... infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal and tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. It offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. The company provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, ESR pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, universal caps, and ECG electrodes. The company was incorporated in 1995 and is based in New Delhi, India. Read more
Incorporated
1995
Chairman
Devendra Mehta
Managing Director
Himanshu Baid
Headquarters
New Delhi, Delhi
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Poly Medicure Ltd is ₹1,240.50 (NSE) and ₹1,235.85 (BSE) as of 19-Mar-2026 IST. Poly Medicure Ltd has given a return of 8.83% in the last 3 years.
The P/E ratio of Poly Medicure Ltd is 36.03 times as on 19-Mar-2026, a 0 premium to its peers’ median range of 36.03 times.
The P/B ratio of Poly Medicure Ltd is 4.19 times as on 19-Mar-2026, a 0 premium to its peers’ median range of 4.19 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
67.10
|
8.22
|
|
2024
|
59.04
|
10.40
|
|
2023
|
51.01
|
7.38
|
|
2022
|
62.11
|
8.38
|
|
2021
|
57.69
|
8.13
|
The 52-week high and low of Poly Medicure Ltd are Rs 2,937.60 and Rs 1,225.10 as of 20-Mar-2026.
Poly Medicure Ltd has a market capitalisation of ₹ 12,527 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Poly Medicure Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-38.60
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.